HPV DNA detection in urine samples of women: "An efficacious and accurate alternative to cervical samples?"
HPV DNA detection in urine samples of women: "An efficacious and accurate alternative to cervical samples?"
Expert Rev Anti Infect Ther. 2019 Sep 13;:
Authors: Pattyn J, Van Keer S, Téblick L, Van Damme P, Vorsters A
Abstract
Cervical cancers are caused by persistent human papillomavirus (HPV) infections [1]. To date, HPV DNA testing using clinician-obtained cervical cells is the reference for identifying cervical infection. However, great interest has been shown for the use of self-sampling methods to detect HPV [2]. One method for self-sampling to be considered is the collection of first-void urine samples. Urinary HPV DNA testing could offer a non-invasive, more accessible and acceptable sampling method in primary and secondary cervical cancer prevention. Recent standardized and optimized protocols have significantly enhanced the sensitivity of urinary HPV detection [3-6]. Furthermore, interesting biomarkers in the triage of high-risk HPV positive women and follow-up of vaccinated women have been identified in first-void urine samples.
PMID: 31519117 [PubMed - as supplied by publisher]
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Infectious Diseases | Vaccines | Women